EGFR and colon carcinoma: As shown by flow cytometry analysis on EGFR-positive human colon carcinoma cell lines Colo205 and HCT116, hu225 IgG and cetuximab bound with similar EC50 values to the target cells, demonstrating that the humanized IgG retained the EGFR binding activity (Supplemental Fig. S1).